Ā | Odds ratio | P | 95% CI |
---|---|---|---|
Any TZD therapy (N = 983) | 1.59 | 0.04 | 1.03ā2.44 |
Age | 1.03 | 0.01 | 1.01ā1.05 |
Biguanide therapy | 1.37 | 0.14 | 0.90ā2.10 |
Sulfonylurea therapy | 0.70 | 0.09 | 0.45ā1.05 |
Glycosolated hemoglobin A1C, % | 0.91 | 0.30 | 0.76ā1.08 |
Body mass index, kg/m2 | 0.97 | 0.08 | 0.94ā1.00 |
Cigarette smoking | 0.61 | 0.13 | 0.33ā1.15 |
High comorbidity conditions | 3.40 | <0.001 | 2.14ā5.39 |
Number of prescription medications | 1.01 | 0.97 | 0.95ā1.07 |
Rosiglitazone therapy (N = 983) | 1.89 | 0.02 | 1.11ā3.19 |
Age | 1.03 | 0.05 | 1.01ā1.05 |
Biguanide therapy | 1.34 | 0.16 | 0.89ā2.04 |
Sulfonylurea therapy | 0.70 | 0.10 | 0.46ā1.07 |
Glycosolated hemoglobin A1C, % | 0.92 | 0.34 | 0.77ā1.09 |
Body mass index, kg/m2 | 0.97 | 0.09 | 0.94ā1.00 |
Cigarette smoking | 0.61 | 0.13 | 0.33ā1.15 |
High comorbidity conditions | 3.32 | <0.001 | 2.10ā5.26 |
Number of prescription medications | 1.00 | 0.92 | 0.95ā1.06 |
Pioglitazone therapy (N = 983) | 1.09 | 0.76 | 0.62ā1.94 |
Age | 1.03 | 0.01 | 1.01ā1.05 |
Biguanide | 1.41 | 0.11 | 0.93ā2.13 |
Sulfonylureas | 0.71 | 0.12 | 0.47ā1.09 |
Glycosolated hemoglobin A1C, % | 0.91 | 0.27 | 0.77ā1.08 |
Body mass index, kg/m2 | 0.98 | 0.12 | 0.91ā1.01 |
Cigarette smoking | 0.62 | 0.13 | 0.33ā1.15 |
High comorbidity conditions | 3.36 | <0.001 | 2.12ā5.32 |
Number of prescription medications | 1.01 | 0.81 | 0.95ā1.07 |